Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nextcure, Inc. (NXTC) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nextcure, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1661059.
Total stock buying since 2019: $25,387,500.
Total stock sales since 2019: $0.
Total stock option exercises since 2019: $94,867.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 0 | $0 | 0 | $0 | 27,229 | $48,195 |
| 2019 | 1,475,000 | $25,387,500 | 0 | $0 | 55,234 | $46,672 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-07 | 0 | $0 | 0 | $0 | 27,229 | $48,195 |
| 2019-11 | 150,000 | $5,512,500 | 0 | $0 | 55,234 | $46,672 |
| 2019-05 | 1,325,000 | $19,875,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-14 | Heller Kevin N. (Chief Medical Officer) | Option Ex | 27,229 | 1.77 | 48,195 |
| 2019-11-27 | Liu Linda (SVP, Research) | Option Ex | 55,234 | .84 | 46,672 |
| 2019-11-15 | Powell Michael | Buy | 150,000 | 36.75 | 5,512,500 |
| 2019-05-13 | Xu Stella (Director) | Buy | 125,000 | 15.00 | 1,875,000 |
| 2019-05-13 | Orbimed Capital Gp Vi Llc (Director) | Buy | 350,000 | 15.00 | 5,250,000 |
| 2019-05-13 | Canaan Partners X Llc (10% Owner) | Buy | 50,000 | 15.00 | 750,000 |
| 2019-05-13 | Khuong Chau Quang (Director) | Buy | 350,000 | 15.00 | 5,250,000 |
| 2019-05-13 | Shannon Timothy M (Director) | Buy | 50,000 | 15.00 | 750,000 |
| 2019-05-13 | Powell Michael | Buy | 400,000 | 15.00 | 6,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NXTC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nextcure, Inc. (symbol NXTC, CIK number 1661059) see the Securities and Exchange Commission (SEC) website.